Jeez-What is this, people? Immunex was the story of the day yesterday, closing up 35+ points, and not a word about it on this board? (Ho Hum, only 35 points, it could have done better)-how?! The fact that (with FDA approval) Enbrel will increase its potential market by 2+million people is astounding!
Also, as a pharmacist, I believe the asthma drug Immunex has in the pipeline may actually overshadow Enbrel's sales when brought to market (with FDA approval, of course). Once a week dosing for asthma would, in my opinion, corner this segment of a HUGE patient-base...
What do you think? Anyone? Anyone? |
